Name: IRWD Income Statement - Ironwood Pharmaceuticals Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IRWD - Ironwood Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

IRWD Income Statement - Ironwood Pharmaceuticals Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	106.5	47.7	122.1	85.2	41.1	90.5	91.6	94.4	74.9	117.6	113.7	107.4	104.1	107.2	108.6	97.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	361.5	296.2	351.4	442.7	410.6	413.8	389.5	428.4	346.6	298.3	274.0	149.6	76.4	22.9	150.2	65.9	43.9	34.3
Cost of Revenue	-	-	-	-	-	-	3.1	23.9	32.8	19.1	1.9	0.0	5.3	7.2	1.0	-	-	-
Gross Profit	-	-	-	-	-	-	386.4	404.5	313.9	279.2	272.1	149.5	71.1	15.7	149.3	-	-
Operating Expenses
Research & Development	89.6	95.1	111.4	116.1	44.3	70.4	88.1	115.0	101.1	88.1	139.5	108.7	101.9	102.4	113.5
Operating Income
Operating Income	200.2	98.5	93.1	(945.4)	250.3	232.3	142.9	120.1	(150.7)	(15.4)	(51.9)	(102.1)	(169.4)	(252.0)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.2	0.5
Tax & Net
Income Tax Expense	69.3	46.0	64.3	83.5	77.4	(327.8)	2.7	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Per Share
EPS Basic	0.63	0.15	0.01	(6.45)	1.13	3.26	0.67	0.14	(1.85)	-	-	-	-	(2.35)	(0.68)	(0.65)
Supplementary Data
EBITDA	-	99.6	94.3	(944.2)	251.7	233.8	145.2	125.7	(146.8)	(9.0)	(41.6)	(90.5)	(157.0)	(240.3)	(61.4)	(56.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	21.9	21.9	22.5	23.4	27.4	25.4	29.8	30.4	25.8	35.7	33.0	34.6	12.8	10.4	11.5	11.5	10.8	31.9	10.9	12.2	15.5	16.3	21.7	22.1	28.0	26.5	27.6	28.8	32.2	12.2	29.2	23.2	36.5	(20.0)	37.1	37.3	33.7	38.4	37.5	31.7
Selling General & Administrative	12.0	19.3	21.9	16.8	24.3	33.6	36.1	37.0	37.6	38.7	36.0	52.5	31.1	28.4	28.6	30.1
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0.4	-	-	-	0.5	-	-	-	0.5	-	-	-	0.3	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	33.9	40.9	46.6	39.9	70.3	59.1	66.0	69.4	63.9	80.0	73.7	1,190.5	44.0	38.8	40.2	41.6

Operating Income
Operating Income	72.6	6.8	75.5	45.3	(29.1)	31.5	25.6	25.0	11.0	37.6	40.0	(1,083.1)	60.1	68.4	68.5	55.7	57.8	56.6	65.2	65.1	45.4	51.4	45.6	32.7	13.2	49.6	65.9	21.6	(16.9)	46.4	(146.6)	(14.7)	(35.9)	84.8	(19.4)	(41.0)	(39.7)	(6.3)	(28.3)	(15.3)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	9.1	7.9	8.4	8.4	8.1	8.9	9.4	7.5	7.2	8.4	9.8	1.8	1.5	1.5	1.5	2.2	2.3	8.0
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(7.4)	(6.4)	(7.5)	(7.5)	(7.2)	(7.5)	(8.3)	(6.1)	(6.1)	(7.2)	(8.1)	6.9	5.8	3.9	1.4	(1.9)	(1.4)
Pre-Tax Income	65.2	0.5	68.0	37.8	(36.3)	24.0	17.4	18.9	5.0	30.4	31.9	(1,076.2)	65.9	72.3	69.9	53.8	56.5

Tax & Net
Income Tax Expense	24.4	2.7	27.9	14.2	1.1	21.7	13.7	19.7	9.1	32.1	18.0	13.3	20.1	23.4	19.6	16.7	17.7	4.9	3.8	(336.9)	0.4	-	1.4	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	40.8	(2.3)	40.1	23.6	(37.4)	2.3	3.6	(0.9)	(4.2)	(1.7)	14.0	(1,089.5)	45.7	48.9	50.3	37.1	38.8
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	40.8	(2.3)	40.1	23.6	(37.4)	2.3	3.6	(0.9)	(4.2)	(1.7)	14.0	(1,089.5)	45.7	48.9	50.3	37.1	38.8
Net Income Attributable To Parent	40.8	(2.3)	40.1	23.6	(37.4)	2.3	3.6	(0.9)	(4.2)	(1.1)	15.3	(1,062.2)	45.7	48.9	50.3	37.1
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	(1.4)	(27.3)	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	40.8	(2.3)	40.1	23.6	(37.4)	2.3	3.6	(0.9)	(4.2)	(1.1)	15.3	(1,062.2)	45.7	48.9	50.3

Per Share
EPS Basic	0.25	-	0.25	0.15	(0.23)	-	0.02	(0.01)	(0.03)	-	0.10	(6.84)	0.30	-	0.33	0.24	0.25	-	0.34	2.42	0.25	-	0.22	0.16	0.02	-	0.13	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	0.24	-	0.23	0.14	(0.23)	-	0.02	(0.01)	(0.03)	-	0.09	(6.84)	0.25	-	0.28	0.21	0.21	-
Shares Basic	163.5	-	162.2	161.7	161.0	-	159.7	159.0	157.7	-	155.9	155.4	154.5	-	153.1	153.3	157.8	-
Shares Diluted	166.7	-	177.8	176.8	161.0	-	160.2	159.0	157.7	-	186.9	155.4	186.7	-	184.5	184.9	189.5	-

Supplementary Data
EBITDA	73.0	-	-	-	(28.6)	-	-	-	11.5	-	-	-	60.4	-	-	-	58.2	-	-	-	45.8	-	-	-	13.9	-	-	-	(16.2)	-	-	-	(34.1)	-	-	-	(36.8)	-	-	-
EBIT	72.6	6.8	75.5	45.3	(29.1)	31.5	25.6	25.0	11.0	37.6	40.0	(1,083.1)	60.1	68.4	68.5	55.7	57.8	56.6	65.2